跳至主要内容
临床试验/NCT05460715
NCT05460715进行中(未招募)不适用

Prospective Multicentre Study to Evaluate the Long-term Performance of Anteverted Femoral Stems in Total Hip Arthroplasty

Medacta International SA1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年7月30日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
300
试验地点
1
主要终点
Evaluate the 10-year survival of the anteverted Quadra-P stem

研究概览

简要总结

This is a Post-Marketing Surveillance of Quadra-P anteverted stem prosthesis.

详细描述

The primary objective of this study is to evaluate the 10-year survival of the anteverted Quadra-P stem in patients operated for primary total hip arthroplasty, according to the inclusion criteria.

Secondary objectives:

  • To assess clinical performance by Harris Hip score collected during preoperative and postoperative visits at 3 months, 1, 2, 5, 7 and 10 years.
  • Assess radiological performance by standard radiographic examination performed preoperatively, postoperatively before discharge and during postoperative visits at 3 months, 1, 2, 5, 7 and 10 years.
  • Assessing the patient's perception of the prosthetic joint by means of FJS questionnaire collected during the preoperative visit and postoperative visits at 3 months and at 1, 2, 5, 7 and 10 years after surgery.
  • Assessment of functional recovery by gait analysis study
  • Collect the rate of complications throughout the course of the study

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects suffering from primary hip arthrosis, post-traumatic arthrosis, dysplasia or avascular necrosis of the femoral head, rheumatoid arthritis
  • Adult subjects between 18 and 75 years of age on the date of surgery
  • Subjects eligible for primary total hip arthroplasty surgery for whom the anterior Quadra-P femoral component will be implanted according to the indications for use of the implant
  • Subjects who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to surgery.
  • For the anatomical-functional subgroup:
  • - Adult subjects aged between 18 and 65 years at the date of surgery who have agreed to undergo the gait analysis study.

排除标准

  • Subjects with acute or chronic infection
  • Subjects with a femoral neck fracture
  • Subjects with mental conditions that impair their ability to consent to the study, to complete required questionnaires or to complete follow-up visits
  • Subjects with severe deformities, at the discretion of the surgeon
  • Subjects with metabolic disorders that may involve bone metabolism for which an uncemented implant would be contraindicated
  • Subjects with muscular atrophy or neuromuscular diseases
  • Subjects allergic to the materials used during surgery
  • Subjects unable or unwilling to provide consent for participation in the study
  • Any other condition not mentioned in the inclusion criteria

结局指标

主要结局

Evaluate the 10-year survival of the anteverted Quadra-P stem

时间窗: 10 years

% survival rate

次要结局

  • Assessing the patient's perception of the prosthetic joint(at 3 months and at 1, 2, 5, 7 and 10 years after surgery.)
  • Collect the rate of complications(at pre-op, immediate post-op, 3 months, 1, 2, 5, 7 and 10 years.)
  • Assess clinical performance(at 3 months, 1, 2, 5, 7 and 10 years.)
  • Assessment of functional recovery(at pre-op, 3 months and at 1 year after surgery.)
  • Assess radiological performance(at pre-op, 3 months, 1, 2, 5, 7 and 10 years.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验